[1] Compston A, Coles A. Multiple sclerosis. Lancet (London, England). 2008; 372(9648): 1502-1517.
[2] Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev. 2010; 9(5): A387-394.
[3] Organization WH. Multiple Sclerosis International Feder- ation.(2008) Atlas: multiple sclerosis resources in the world 2008. Geneva: World Health Organization.
[4] Mackenzie ER, Rakel B. Complementary and alternative medicine for older adults: A guide to holistic approaches to healthy aging: Springer Publishing Company; 2006.
[5] Hirsch A. Functionalization of single walled carbon nano- tubes. Angew Chem Int Ed. 2002; 41(11): 1853-1859.
[6] Zang J-L, Yuan Q, Wang F-C, Zhao Y-P. A comparative study of Young’s modulus of single-walled carbon nanotube by CPMD, MD and first principle simulations. Comput Mater Sci. 2009; 46(3): 621-625.
[7] Kong J, Franklin NR, Zhou C, Chapline MG, Peng S, Cho K, Dai H. Nanotube molecular wires as chemical sensors. Science. 2000; 287(5453): 622-625.
[8] Iijima S. Helical microtubules of graphitic carbon. Nature. 1991; 354(6348): 56-8.
[9] Ghosh S, Sood AK, Kumar N. Carbon nanotube flow sensors. Science. 2003; 299(5609): 1042-1044.
[10] Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol. 2005; 9(6): 674-679.
[11] Kong H, Zhou M, Lin G-D, Zhang H-B. Pt catalyst supported on multi-walled carbon nanotubes for hydrogenation-dearomatization of toluene and tetralin. Catal Lett. 2010; 135(1-2): 83-90. [12] Kostarelos K. Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science. Adv Colloid Interface Sci. 2003; 106(1): 147-168.
[13] Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008; 68(16): 6652-6660.
[14] Gallo M, Favila A, Glossman-Mitnik D. DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chem Phys Lett 2007; 447(1): 105-109.
[15] Liu Z, Winters M, Holodniy M, Dai H. siRNA Delivery into Human T Cells and Primary Cells with Carbon Nanotube Transporters. Angew Chem Int Ed. 2007; 46(12): 2023-2027.
[16] Kam NWS, Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc. 2005; 127(16): 6021-6026.
[17] Saito R, Dresselhaus G, Dresselhaus MS. Physical properties of carbon nanotubes: World Scientific; 1998.
[18] Feazell RP, Nakayama-Ratchford N, Dai H, Lippard SJ. Soluble single-walled carbon nanotubes as longboat delivery systems for platinum (IV) anticancer drug design. J Am Chem Soc. 2007; 129(27): 8438-8439.
[19] Dhar S, Liu Z, Thomale J, Dai H, Lippard SJ. J Am Chem Soc. 2008; 130(34): 11467-11476.
[20] Pastorin G, Wu W, Wieckowski S, Briand J-P, Kostarelos K, Prato M, Prato M, Bianco A. Double functionali- zation of carbon nanotubes for multimodal drug delivery
Chem Comm. 2006; 11: 1182-1184.
[21] Ali-Boucetta H, Al-Jamal KT, McCarthy D, Prato M, Bianco A, Kostarelos K. Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Comm. 2008(4):459-461.
[22] Liu Z, Sun X, Nakayama-Ratchford N, Dai H. Supr- amolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano. 2007; 1(1): 50-56.
[23] Risi G, Bloise N, Merli D, Icaro-Cornaglia A, Profumo A, Fagnoni M, Quartarone E, Imbriani M, Visai L.RSC Advances. In vitro study of multiwall carbon nanotubes (MWCNTs) with adsorbed mitoxantrone (MTO) as a drug delivery system to treat breast cancer .2014; 4(36): 18683-18693.
[24] Delley B. An all electron numerical method for solving the local density functional for polyatomic molecules. J Chem Phys. 1990; 92(1): 508-517.
[25] Perdew JP, Wang Y. Accurate and simple analytic representation of the electron-gas correlation energy. Phys Rev B. 1992; 45(23): 13244.
[26] Chattaraj PK, Sarkar U, Roy DR. Electrophilicity index. Chem Rev. 2006; 106(6): 2065-2091.
[27] Hazarika KK, Baruah NC, Deka RC. Molecular structure and reactivity of antituberculosis drug molecules isoniazid, pyrazinamide, and 2-methylheptylisonicotinate: a density functional approach. Struct Chem. 2009; 20(6):1079-1085.
[28] Andzelm J, Kölmel C, Klamt A. Incorporation of solvent effects into density functional calculations of molecular energies and geometries. J Chem Phys. 1995; 103(21): 9312-9320.
[29] Lu X, Tian F, Xu X, Wang N, Zhang Q. A theoretical exploration of the 1, 3-dipolar cycloadditions onto the sidewalls of (n, n) armchair single-wall carbon nanotubes. J Am Chem Soc. 2003; 125(34): 10459-10464.
[30] Saikia N, Deka RC. Theoretical study on pyrazinamide adsorption onto covalently functionalized (5, 5) metallic single-walled carbon nanotube. Chem Phys Lett. 2010; 500(1): 65-70.
[31] Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem. 2004; 116(39): 5354-5358.